Open access

Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al
Jeffrey Weber, Mario Mandala, Paolo Antonio Ascierto, James Larkin

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e004347; DOI: 10.1136/jitc-2021-004347
Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054
Alexander Eggermont, Michal Kicinski, Stefan Suciu

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e004272; DOI: 10.1136/jitc-2021-004272
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors
Chantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman, Nikki M Loof, Gregor Sturm, Tom H Wesselink, Ramon Arens, Sanne Boekestijn, Ilina Ehsan, Mariette I E van Poelgeest, Francesca Finotello, Hubert Hackl, Zlatko Trajanoski, Peter ten Dijke, Veronique M Braud, Marij J P Welters, Sjoerd H van der Burg

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003995; DOI: 10.1136/jitc-2021-003995
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer
Kazuki Nishimura, Kyosuke Nishio, Kensuke Hirosuna, Kazumasa Komura, Takuo Hayashi, Wataru Fukuokaya, Ayako Ura, Taizo Uchimoto, Ko Nakamura, Tatsuo Fukushima, Yusuke Yano, Nobushige Takahashi, Keita Nakamori, Shoko Kinoshita, Tomohisa Matsunaga, Takeshi Tsutsumi, Takuya Tsujino, Kohei Taniguchi, Tomohito Tanaka, Hirofumi Uehara, Kiyoshi Takahara, Teruo Inamoto, Yoshinobu Hirose, Takahiro Kimura, Shin Egawa, Haruhito Azuma

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003868; DOI: 10.1136/jitc-2021-003868
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
Shinya Abe, Hiroshi Nagata, Erika J Crosby, Yoshiyuki Inoue, Kensuke Kaneko, Cong-Xiao Liu, Xiao Yang, Tao Wang, Chaitanya R Acharya, Pankaj Agarwal, Joshua Snyder, William Gwin, Michael A Morse, Pei Zhong, Herbert Kim Lyerly, Takuya Osada

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003717; DOI: 10.1136/jitc-2021-003717
Short-course neoadjuvant in situ vaccination for murine melanoma
Taylor J Aiken, David Komjathy, Matthew Rodriguez, Ashley Stuckwisch, Arika Feils, Vladimir Subbotin, Jen Birstler, Stephen D Gillies, Alexander L Rakhmilevich, Amy K Erbe, Paul M Sondel

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003586; DOI: 10.1136/jitc-2021-003586
Large-scale manufacturing and characterization of CMV-CD19CAR T cells
Xiuli Wang, Ryan Urak, Miriam Walter, Min Guan, Tianxu Han, Vibhuti Vyas, Sheng-Hsuan Chien, Brenna Gittins, Mary C Clark, Sally Mokhtari, Angelo Cardoso, Don J Diamond, John Zaia, Stephen J Forman, Ryotaro Nakamura

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003461; DOI: 10.1136/jitc-2021-003461
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors
Jiemiao Hu, Qing Yang, Wendong Zhang, Hongwei Du, Yuhui Chen, Qingnan Zhao, Long Dao, Xueqing Xia, Fowlkes Natalie Wall, Zhongting Zhang, Kris Mahadeo, Richard Gorlick, S Kopetz, Gianpietro Dotti, Shulin Li

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003633; DOI: 10.1136/jitc-2021-003633
Immuno-oncology trends: preclinical models, biomarkers, and clinical development
Maryland Rosenfeld Franklin, Suso Platero, Kamal S Saini, Giuseppe Curigliano, Steven Anderson

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003231; DOI: 10.1136/jitc-2021-003231
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma
Weixiong Yang, Xiangbin Xing, Sai-Ching Jim Yeung, Siyu Wang, Wenfang Chen, Yong Bao, Fang Wang, Shiting Feng, Fang Peng, Xiaoyan Wang, Shuling Chen, Minghui He, Ning Zhang, Honglei Wang, Bo Zeng, Zhenguo Liu, Biniam Kidane, Christopher W Seder, Kazuo Koyanagi, Yaron Shargall, Honghe Luo, Sui Peng, Chao Cheng

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003497; DOI: 10.1136/jitc-2021-003497

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages